Research Article
The Effect of Early Treatment with Intravenous Magnesium Sulfate on the Incidence of Cardiac Comorbidities in Hospitalized Stroke Patients
Table 4
Dichotomized demographic and clinical characteristics in stroke patients with and without CAEs.
| | Patients with CAEs () | Patients without CAEs () | value |
| | Age (mean, SD) | 75.7 (11.1) | 68.5 (13.5) | <0.0001 | | Sex female (, percent) | 72 (45.7) | 400 (41.4) | 0.38 | | Diagnosis, (%) | | | | | Acute cerebral ischemia | 124 (78.0) | 685 (70.8) | 0.18 | | Intracranial hemorrhage | 33 (20.8) | 244 (25.2) | | Stroke mimic | 2 (1.3) | 37 (3.8) | | Race, (%) | | | | | White | 119 (74.8) | 735 (76.0) | 0.97 | | Black/African American | 21 (13.2) | 136 (14.1) | | Asian | 17 (10.7) | 85 (8.8) | | Other | 2 (1.2) | 10 (1.0) | | Ethnicity–Hispanic, (%) | 25 (15.7) | 245 (25.4) | 0.01 | | Medical history | | | | | Hypertension, (%) | 131 (82.4) | 746 (77.2) | 0.18 | | Diabetes, (%) | 44 (27.7) | 206 (21.3) | 0.08 | | Hyperlipidemia, (%) | 86 (54.1) | 447 (46.3) | 0.07 | | Atrial fibrillation, (%) | 57 (35.8) | 197 (20.4) | <0.0001 | | CAD, (%) | 46 (28.9) | 199 (20.6) | 0.02 | | MI, (%) | 28 (17.6) | 97 (10.0) | 0.01 | | CABG, (%) | 3 (1.9) | 27 (2.8) | 0.78 | | Valvular heart disease, (%) | 18 (11.3) | 66 (6.8) | 0.05 | | Prior stroke, (%) | 12 (7.5) | 74 (7.7) | 1.0 | | Tobacco use, (%) | 19 (11.9) | 180 (18.6) | 0.04 | | Any alcohol use, (%) | 56 (35.2) | 579 (40.1) | 0.25 | | Time intervals (mins), median (IQR) | | | | | Onset to paramedic evaluation | 16 (7-36) | 16 (8-35) | 0.98 | | Onset to ED arrival | 58 (46-85) | 58 (46-78) | 0.88 | | Severity scores | | | | | Prehospital GCS, median (IQR) | 15 (12-15) | 15 (14-15) | <0.0001 | | Prehospital LAMS, median (IQR) | 5 (3-5) | 4 (3-5) | 0.001 | | Serum magnesium level mean (SD) | 3.0 (1.4) | 2.8 (1.2) | 0.05 |
|
|
